
Blog
New immunotherapy targets leukemia at its root
Acute myeloid leukemia (AML) is one of the most aggressive

Acute myeloid leukemia (AML) is one of the most aggressive

Conventional gene-editing technologies, such as CRISPR Cas9, have been limited

Chimeric Antigen Receptor (CAR)-T cells have revolutionized cancer therapy, by

CAR-T cell therapy is one of the most promising cancer

A recent clinical trial published in Nature has demonstrated promising

Researchers have introduced a next-generation CAR T-cell therapy, called EchoBack

One of the functions of Natural Killer (NK) cells is

Chimeric Antigen Receptor T-cell (CAR-T) therapy has revolutionized cancer treatment

Neuroblastoma, a highly aggressive childhood cancer, presents a high risk